I think it will be the icebreaker. This can get things done. |
The companies are merging out of necessity because sales of their top-selling medicines are stagnating and they have a shortage of early-stage experimental medicines in their pipelines. |
The results are very positive. Pfizer has fundamentals working in its favor. |